Alexion Pharmaceuticals shows Mean Deviation of 1.1 and Risk Adjusted Performance of 0.01. Alexion Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Alexion Pharmaceuticals which can be compared to its rivals. Please confirm Alexion PharmaceuticalsStandard Deviation as well as the relationship between Maximum Drawdown and Expected Short fall to decide if Alexion Pharmaceuticals is priced correctly providing market reflects its regular price of 126.25 per share. Given that Alexion Pharmaceuticals has Jensen Alpha of 0.0, we suggest you validate Alexion Pharmaceuticals prevailing market performance to make sure the company can sustain itself at future point.
The output start index for this execution was six with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alexion Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Alexion Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Alexion Pharmaceuticals. You can use it to identify possible trend reversals for Alexion Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alexion Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Alexion Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Alexion Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.48 % which means Alexion Pharmaceuticals will continue generating value for investors. It has 34 observation points and a regression sum of squares at 191.44, which is the sum of squared deviations for the predicted Alexion Pharmaceuticals price change compared to its average price change.
Current Sentiment - ALXN
Alexion Pharmaceuticals Investor Sentiment
Majority of Macroaxis users are presently bullish on Alexion Pharmaceuticals. What is your sentiment towards investing in Alexion Pharmaceuticals? Are you bullish or bearish?